Business
Currency:USD
2024/FY
Stock NameRevenueRatio
BELBUCA211.27M33.46%
Xtampza Extended-release (ER)191.33M30.30%
Nucynta Immediate-release (IR)100.74M15.95%
Nucynta Extended-release (ER)75.77M12.00%
Jornay37.24M5.90%
Symproic15.1M2.39%
View all
Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States631.45M100.00%